Rongcan Biotech
Latest round
- Series A
Last raised
- Dec 2023
Total raised
- $14M
Investors
- 5
About Rongcan Biotech
Established in 2020 and based in Wuhu, China, Rongcan Biotech operates as a nucleic acid drug developer, dedicated to the development and industrialization of gene drugs. The company's core technical members graduated from MIT and Harvard Medical School. It has established a joint laboratory of drug slow-release technology with Shanghai Jiao Tong University School of Pharmacy and has cooperated with WuXi AppTec Group and HuiGene Therapeutics. Rongcan Biotech has established a nucleic acid drug RTP R&D technology platform to research and develop mRNA and SiRNA drugs. The company's product pipelines cover drugs in respiratory, cardiovascular, and solid tumors, as well as mRNA vaccines for infectious diseases.
Who invested in Rongcan Biotech
5 investors across 2 rounds
See all investors in Rongcan Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Rongcan Biotech
Who invested in Rongcan Biotech?
Rongcan Biotech has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rongcan Biotech raised?
Rongcan Biotech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Rongcan Biotech last raise money?
Rongcan Biotech's most recent round on record is a Series A, in Dec 2023.
What does Rongcan Biotech do?
Established in 2020 and based in Wuhu, China, Rongcan Biotech operates as a nucleic acid drug developer, dedicated to the development and industrialization of gene drugs.
Where is Rongcan Biotech headquartered?
Rongcan Biotech is headquartered in Shanghai, China.
Which VCs invest in companies like Rongcan Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Rongcan Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Rongcan Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.